CN113730481B - Traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, suppository and preparation method - Google Patents
Traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, suppository and preparation method Download PDFInfo
- Publication number
- CN113730481B CN113730481B CN202110975590.XA CN202110975590A CN113730481B CN 113730481 B CN113730481 B CN 113730481B CN 202110975590 A CN202110975590 A CN 202110975590A CN 113730481 B CN113730481 B CN 113730481B
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- traditional chinese
- chinese medicine
- suppository
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 141
- 239000000203 mixture Substances 0.000 title claims abstract description 116
- 239000000829 suppository Substances 0.000 title claims abstract description 90
- 208000004232 Enteritis Diseases 0.000 title claims abstract description 73
- 241000701931 Canine parvovirus Species 0.000 title claims abstract description 69
- 238000002360 preparation method Methods 0.000 title claims abstract description 41
- 239000002994 raw material Substances 0.000 claims abstract description 80
- 240000004980 Rheum officinale Species 0.000 claims abstract description 79
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 79
- 241000037740 Coptis chinensis Species 0.000 claims abstract description 78
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 75
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 59
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 59
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 49
- 235000010586 Sophora japonica Nutrition 0.000 claims abstract description 10
- 244000046101 Sophora japonica Species 0.000 claims abstract description 10
- 239000000284 extract Substances 0.000 claims description 104
- 239000000243 solution Substances 0.000 claims description 99
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 62
- 238000001035 drying Methods 0.000 claims description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 50
- 235000014360 Punica granatum Nutrition 0.000 claims description 47
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 41
- 241001106477 Paeoniaceae Species 0.000 claims description 41
- 241000219784 Sophora Species 0.000 claims description 35
- 238000002156 mixing Methods 0.000 claims description 33
- 244000061520 Angelica archangelica Species 0.000 claims description 31
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 31
- 241000219061 Rheum Species 0.000 claims description 29
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 29
- 240000006688 Telosma cordata Species 0.000 claims description 28
- 235000017352 Telosma cordata Nutrition 0.000 claims description 28
- 239000000843 powder Substances 0.000 claims description 26
- 238000001914 filtration Methods 0.000 claims description 22
- 240000002853 Nelumbo nucifera Species 0.000 claims description 19
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 19
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 19
- 235000004347 Perilla Nutrition 0.000 claims description 19
- 244000124853 Perilla frutescens Species 0.000 claims description 19
- 244000062189 Picria fel-terrae Species 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 19
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 17
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 16
- 239000007864 aqueous solution Substances 0.000 claims description 13
- 238000005303 weighing Methods 0.000 claims description 13
- 241000282465 Canis Species 0.000 claims description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 238000000465 moulding Methods 0.000 claims description 12
- 241001078983 Tetradium ruticarpum Species 0.000 claims description 11
- 238000010992 reflux Methods 0.000 claims description 11
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims description 10
- 244000236658 Paeonia lactiflora Species 0.000 claims description 10
- 125000005456 glyceride group Chemical group 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- 108010059892 Cellulase Proteins 0.000 claims description 9
- 229940106157 cellulase Drugs 0.000 claims description 9
- 238000002844 melting Methods 0.000 claims description 9
- 230000008018 melting Effects 0.000 claims description 9
- 244000148137 Patrinia villosa Species 0.000 claims description 6
- 235000019109 Patrinia villosa Nutrition 0.000 claims description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 claims description 6
- 239000009188 angelicae sinensis extract Substances 0.000 claims description 6
- 239000000469 ethanolic extract Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 239000012065 filter cake Substances 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 244000111489 Gardenia augusta Species 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 3
- 238000002137 ultrasound extraction Methods 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 2
- 244000294611 Punica granatum Species 0.000 claims 3
- 239000010404 Scutellaria baicalensis extract Substances 0.000 claims 1
- 238000001746 injection moulding Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 44
- 229940079593 drug Drugs 0.000 abstract description 42
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 208000001848 dysentery Diseases 0.000 abstract description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 48
- 230000000052 comparative effect Effects 0.000 description 45
- 241000219991 Lythraceae Species 0.000 description 44
- 239000008280 blood Substances 0.000 description 39
- 210000004369 blood Anatomy 0.000 description 38
- 238000010926 purge Methods 0.000 description 31
- 240000001972 Gardenia jasminoides Species 0.000 description 28
- 150000002148 esters Chemical class 0.000 description 25
- 210000000936 intestine Anatomy 0.000 description 25
- 239000003921 oil Substances 0.000 description 20
- 235000019198 oils Nutrition 0.000 description 20
- 230000008673 vomiting Effects 0.000 description 19
- 235000002598 Inula helenium Nutrition 0.000 description 17
- 244000116484 Inula helenium Species 0.000 description 17
- 239000003240 coconut oil Substances 0.000 description 17
- 235000019864 coconut oil Nutrition 0.000 description 17
- 201000010099 disease Diseases 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 241000283690 Bos taurus Species 0.000 description 16
- 206010012735 Diarrhoea Diseases 0.000 description 15
- 208000032843 Hemorrhage Diseases 0.000 description 15
- 230000000740 bleeding effect Effects 0.000 description 15
- 241000218202 Coptis Species 0.000 description 13
- 235000002991 Coptis groenlandica Nutrition 0.000 description 13
- 206010047700 Vomiting Diseases 0.000 description 13
- 230000036760 body temperature Effects 0.000 description 11
- 238000011282 treatment Methods 0.000 description 11
- 208000015181 infectious disease Diseases 0.000 description 10
- 241000207929 Scutellaria Species 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 241000700605 Viruses Species 0.000 description 8
- 239000002671 adjuvant Substances 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 241000721047 Danaus plexippus Species 0.000 description 7
- 241000628997 Flos Species 0.000 description 7
- 241000972672 Phellodendron Species 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 229940076742 senna leaves Drugs 0.000 description 6
- 239000003053 toxin Substances 0.000 description 6
- 210000004916 vomit Anatomy 0.000 description 6
- 244000272264 Saussurea lappa Species 0.000 description 5
- 235000006784 Saussurea lappa Nutrition 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 5
- 239000003610 charcoal Substances 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 4
- 208000005156 Dehydration Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 235000019482 Palm oil Nutrition 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000013872 defecation Effects 0.000 description 4
- 230000018044 dehydration Effects 0.000 description 4
- 238000006297 dehydration reaction Methods 0.000 description 4
- 239000002540 palm oil Substances 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 229940126680 traditional chinese medicines Drugs 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 3
- 241001253169 Asystasia gangetica Species 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000006838 adverse reaction Effects 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 239000003212 astringent agent Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 230000003449 preventive effect Effects 0.000 description 3
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical compound [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 208000003322 Coinfection Diseases 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 235000018958 Gardenia augusta Nutrition 0.000 description 2
- 235000014220 Rhus chinensis Nutrition 0.000 description 2
- 240000003152 Rhus chinensis Species 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- HPTYUNKZVDYXLP-UHFFFAOYSA-N aluminum;trihydroxy(trihydroxysilyloxy)silane;hydrate Chemical compound O.[Al].[Al].O[Si](O)(O)O[Si](O)(O)O HPTYUNKZVDYXLP-UHFFFAOYSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229910052621 halloysite Inorganic materials 0.000 description 2
- 230000010196 hermaphroditism Effects 0.000 description 2
- 230000000521 hyperimmunizing effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 208000034782 Lid sulcus deepened Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000008071 Parvoviridae Infections Diseases 0.000 description 1
- 206010057343 Parvovirus infection Diseases 0.000 description 1
- 241000972673 Phellodendron amurense Species 0.000 description 1
- 241000282330 Procyon lotor Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 240000003243 Thuja occidentalis Species 0.000 description 1
- 235000008109 Thuja occidentalis Nutrition 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 241000282458 Ursus sp. Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000004913 chyme Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 1
- 239000001289 litsea cubeba fruit oil Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000002333 serotherapy Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/754—Evodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Insects & Arthropods (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Animal Husbandry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to the technical field of veterinary medicines, and particularly relates to a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, a suppository and a preparation method. The traditional Chinese medicine composition is prepared from raw materials including coptis chinensis, scutellaria baicalensis, rheum officinale, angelica sinensis, radix paeoniae alba, sophora japonica, herba patriniae, cacumen biotae, fructus evodiae and pericarpium granati, is used for treating canine parvovirus enteritis through rectal administration, has the effects of clearing heat, promoting blood circulation, stopping dysentery and recovering yin, can take effect quickly, is high in cure rate, does not have side effects, and is also suitable for puppies. The suppository is more convenient for clinical use after being prepared into the suppository.
Description
Technical Field
The invention relates to the technical field of traditional Chinese veterinary medicines, and in particular relates to a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, a suppository and a preparation method.
Background
The canine parvovirus disease is an acute infectious disease which is caused by infection of dogs by Canine Parvovirus (CPV) and is mainly characterized by hemorrhagic enteritis, is mainly characterized by severe vomiting, diarrhea and obvious reduction of leucocytes, is one of common clinical diseases, has high mortality, high development speed and strong infectivity, and is one of the most important virulent infectious diseases damaging dogs.
CPV primarily infects dogs, occurring in dogs of various ages, and mostly occurs in puppies of 3 to 4 months of age. The canine parvovirus enteritis generally has a incubation period of 7-14 days, the initial body temperature of the canine parvovirus enteritis rises to 40 ℃, the appetite is exhausted, dehydration symptoms are accompanied, and then vomit and diarrhea occur, the excrement is thin and stinky and is yellow or gray yellow, the excrement contains a large amount of mucus and mucous membrane, and the excrement is tomato juice-like, has blood filaments and is stinky. Late stage of urinary incontinence, sunken eyes, slow reaction, yellow tongue coating and bad breath. As the virus antigen drifts, the virus can infect animals such as cats, bears, raccoon dogs and the like.
The disease is acute in onset and short in course, if the disease is not treated in time, the dog can die, but no specific therapy is available at present, mainly dehydration is corrected according to symptomatic treatment of the disease, and hyper-immune serum therapy, antibiotic therapy and the like are assisted to prevent secondary infection. On one hand, the existing administration mode is infusion treatment, and the coordination degree of the sick dogs is poor; on the other hand, antibiotics are easy to cause adverse reactions of different degrees, especially for puppies, the use of antibiotics is easy to cause body damage, for example, quinolones can cause cartilage dysplasia of puppies, so that the antibiotics need to be used with caution. In addition, the cured dogs still carry viruses, and the viruses are discharged out of the body along with excrement, urine and vomit to pollute the surrounding environment, so that other dogs are infected with diseases, and the diseases are difficult to completely eliminate when the diseases occur in the dog groups.
Disclosure of Invention
Aiming at the technical problems in the prior art, the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, a suppository and a preparation method. The traditional Chinese medicine composition can exert curative effect by rectal administration, is convenient to administer, and has the advantages of quick response, high cure rate and good prevention effect.
In order to solve the above technical problems, a first aspect of the embodiments of the present invention provides a traditional Chinese medicine composition for preventing and treating canine parvoviral enteritis, comprising the following raw materials: coptis root, scutellaria baicalensis, rheum officinale, angelica sinensis, white paeony root, at least one of lotus plumule, sophora flower and gardenia, at least one of rheum officinale, picria fel-terrae lour, patrinia, chinese violet and cacumen biotae, at least one of perilla stem, fructus evodiae and costus root, and at least one of halloysite, gallnut and pomegranate rind.
The Chinese medicinal composition is used for treating canine parvovirus enteritis by rectal administration, has the effects of clearing heat, promoting blood circulation, stopping dysentery and recovering yin, can take effect quickly, has no side effect, and is also suitable for puppies.
Coptis root is bitter and cold, clears heat and dries dampness, and purges fire and detoxifies;
the scutellaria is bitter and cold, clears heat and dries dampness, purges fire and detoxifies;
rhubarb, radix et rhizoma Rhei, being bitter and cold, purges heat and purges intestines, cools blood and detoxifies, breaks accumulation and removes stasis;
the angelica sinensis is sweet, pungent and warm, and has the effects of enriching and nourishing blood, promoting blood circulation to relieve pain, moistening dryness and relaxing bowels;
white peony root, radix Paeoniae alba is bitter, sour and slightly cold, calms the liver, relieves pain, nourishes blood and astringes yin;
the lotus plumule is bitter and cold, clears heart fire, calms liver fire, communicates heart and kidney, and astringes essence to stop bleeding;
the sophora flower is bitter and slightly cold, and has the effects of cooling blood, stopping bleeding, clearing liver and purging fire;
fructus Gardeniae is bitter and cold, has effects in purging pathogenic fire, relieving restlessness, clearing away heat, promoting urination, cooling blood, and removing toxic substance;
the rhubarb is pungent, bitter and cool, has the functions of clearing away heat and toxic material, cooling blood and stopping bleeding, removing blood stasis and detumescence, and killing parasites;
the picria felterrae lour is bitter and cool, and has the effects of clearing away heat and toxic materials, relieving swelling and pain;
herba Patriniae is pungent, bitter and cool, and has effects of clearing away heat and toxic materials, removing blood stasis, relieving pain, relieving swelling, and expelling pus;
the Chinese violet is bitter, pungent and cold, and has the effects of clearing away heat and toxic materials, cooling blood and relieving swelling;
the arborvitae tops are bitter, astringent and cold, cool blood and stop bleeding;
the perilla stem is pungent and warm, regulates qi, relieves epigastric distention, and relieves stagnation and pain;
the evodia rutaecarpa is pungent, bitter and hot, warms the middle-jiao to relieve pain, and regulates qi to arrest vomiting;
the costustoot is pungent, bitter and warm, warms the middle warmer, promotes qi circulation and relieves pain;
halloysitum rubrum is sweet, sour, astringent and warm, and has effects of astringing intestine, stopping bleeding, promoting granulation, and healing sore;
galla chinensis is sour, astringent and cold, and has effects of lowering fire, stopping bleeding, relieving diarrhea with astringents, eliminating dampness and healing sore;
pomegranate rind is sour, astringent and warm, astringes intestines to check diarrhea, stops bleeding and expels parasites.
The medicines are compatible, and the obtained composition has the effects of clearing heat, activating blood, stopping dysentery and collecting yin, and is very suitable for treating canine parvovirus enteritis.
Preferably, the traditional Chinese medicine composition can comprise the following raw materials in parts by weight: 27 to 36 parts of coptis chinensis, 20 to 29 parts of scutellaria baicalensis, 30 to 50 parts of rheum officinale, 30 to 50 parts of angelica, 28 to 37 parts of white paeony root, 10 to 15 parts of lotus plumule, 8 to 17 parts of gardenia, 10 to 17 parts of rheum officinale, 12 to 18 parts of herba patriniae, 40 to 60 parts of perilla stem and 20 to 30 parts of gallnut. In the composition, the coptis root and the scutellaria root are used as monarch drugs for clearing heat and drying dampness, purging fire and detoxifying, and the angelica and the white paeony root are used for enriching the blood and nourishing the blood, astringing yin and relieving pain; rhubarb, radix et rhizoma Rhei purges heat and purges intestines, eliminates dampness-heat accumulation stagnation in stomach and intestine, is matched with lotus plumule, cape jasmine fruit, rhubarb and herba Patriniae to clear heat and calm the liver, cool blood and stop bleeding, and is used as a ministerial drug; perilla stem, fructus Perillae, as an adjuvant drug, regulates qi-flowing for relieving pain, galla chinensis, astringes intestine to stop diarrhea, promotes granulation and heals wound. The further preferable mixture ratio of the raw materials is as follows: 30 to 33 parts of coptis chinensis, 23 to 26 parts of scutellaria baicalensis, 35 to 45 parts of rheum officinale, 35 to 45 parts of angelica sinensis, 31 to 35 parts of radix paeoniae alba, 11 to 13 parts of lotus plumule, 10 to 14 parts of gardenia, 12 to 15 parts of rheum officinale, 14 to 17 parts of herba patriniae, 45 to 55 parts of perilla stem and 22 to 27 parts of gallnut. The further preferable mixture ratio is as follows: 31 parts of coptis chinensis, 25 parts of scutellaria baicalensis, 40 parts of rheum officinale, 40 parts of angelica sinensis, 33 parts of radix paeoniae alba, 12 parts of lotus plumule, 13 parts of gardenia, 13 parts of rheum officinale, 16 parts of herba patriniae, 50 parts of perilla stem and 25 parts of gallnut.
Preferably, the traditional Chinese medicine composition can also comprise the following raw materials in parts by weight: 27 to 36 parts of coptis chinensis, 20 to 29 parts of scutellaria baicalensis, 30 to 50 parts of rheum officinale, 30 to 50 parts of angelica, 28 to 37 parts of white paeony root, 25 to 32 parts of sophora flower, 15 to 23 parts of picria felterrae lour, 5 to 12 parts of Chinese violet, 15 to 22 parts of cacumen biotae, 30 to 42 parts of costustoot and 18 to 22 parts of pomegranate bark. In the composition, the coptis root and the scutellaria root are used as monarch drugs for clearing heat and drying dampness, purging fire and detoxifying, and the angelica and the white paeony root are used for enriching the blood and nourishing the blood, astringing yin and relieving pain; rhubarb, radix et rhizoma Rhei purges heat and purges intestines, eliminates dampness-heat accumulation in stomach and intestine, is matched with flos Sophorae Immaturus, picria fel-terrae lour, herba Violae and cacumen Platycladi to cool blood and stop bleeding, clear heat and remove toxicity, and is used as a ministerial drug; mu Xiang warms the middle-jiao to alleviate pain, gu Pi astringes intestine to stop diarrhea and prevents collapse, so it is used as adjuvant drug. The further preferable mixture ratio of the raw materials is as follows: 30 to 33 parts of coptis chinensis, 23 to 26 parts of scutellaria baicalensis, 35 to 45 parts of rheum officinale, 35 to 45 parts of angelica, 31 to 35 parts of radix paeoniae alba, 27 to 30 parts of sophora flower, 17 to 21 parts of picria felterrae lour, 7 to 10 parts of Chinese violet, 17 to 20 parts of cacumen biotae, 34 to 39 parts of elecampane and 19 to 21 parts of pomegranate rind. The further preferable mixture ratio is as follows: 32 parts of coptis chinensis, 24 parts of scutellaria baicalensis, 40 parts of rheum officinale, 40 parts of angelica sinensis, 33 parts of radix paeoniae alba, 29 parts of sophora flower, 19 parts of picria felterrae lour, 8 parts of Chinese violet, 18 parts of cacumen biotae, 36 parts of elecampane and 20 parts of pomegranate bark.
Preferably, the traditional Chinese medicine composition can also comprise the following raw materials in parts by weight: 27 to 36 parts of coptis chinensis, 20 to 29 parts of scutellaria baicalensis, 30 to 50 parts of rheum officinale, 30 to 50 parts of Chinese angelica, 28 to 37 parts of white paeony root, 25 to 32 parts of sophora japonica, 23 to 32 parts of herba patriniae, 16 to 23 parts of cacumen platycladi, 30 to 38 parts of fructus evodiae and 18 to 22 parts of pericarpium granati. In the composition, the coptis and the scutellaria clear heat and dry dampness, purge fire and remove toxicity, and the angelica and the white paeony root enrich the blood and nourish the blood, astringe yin and relieve pain are monarch drugs; rhubarb, radix et rhizoma Rhei purges heat and intestines, eliminates dampness-heat accumulation in stomach and intestines, is matched with flos Sophorae Immaturus, herba Patriniae and cacumen Platycladi to cool blood and stop bleeding, purge fire and remove toxicity, and is used as a ministerial drug; evodia rutaecarpa, fructus evodiae, as an adjuvant drug, has the effects of warming the middle-jiao to alleviate pain, regulating qi to arrest vomiting, and pomegranate bark, pericarpium granati, as an astringent, relieving diarrhea and preventing collapse. The further preferable mixture ratio of the raw materials is as follows: 30 to 34 parts of coptis chinensis, 22 to 26 parts of scutellaria baicalensis, 35 to 45 parts of rheum officinale, 35 to 45 parts of angelica, 30 to 34 parts of white paeony root, 26 to 30 parts of sophora flower, 26 to 30 parts of herba patriniae, 18 to 22 parts of cacumen biotae, 32 to 36 parts of fructus evodiae and 18 to 22 parts of pomegranate bark. The more preferable mixture ratio is as follows: 32 parts of coptis chinensis, 24 parts of scutellaria baicalensis, 40 parts of rheum officinale, 40 parts of angelica sinensis, 32 parts of radix paeoniae alba, 28 parts of sophora flower, 28 parts of patrinia, 20 parts of cacumen biotae, 34 parts of fructus evodiae and 20 parts of pomegranate rind.
Preferably, the traditional Chinese medicine composition can also comprise the following raw materials in parts by weight: 27 to 36 parts of coptis chinensis, 20 to 29 parts of scutellaria baicalensis, 30 to 50 parts of rheum officinale, 30 to 50 parts of angelica, 28 to 37 parts of radix paeoniae alba, 16 to 22 parts of sophora japonica, 5 to 13 parts of gardenia, 12 to 16 parts of rheum officinale, 25 to 32 parts of philippine violet herb, 15 to 23 parts of evodia rutaecarpa, 15 to 23 parts of costustoot, 12 to 19 parts of red halloysite and 10 to 18 parts of pomegranate bark. In the composition, the coptis root and the scutellaria root are used as monarch drugs for clearing heat and drying dampness, purging fire and detoxifying, and the angelica and the white paeony root are used for enriching the blood and nourishing the blood, astringing yin and relieving pain; rhubarb, radix et rhizoma Rhei purges heat and purges intestines, eliminates the stagnation of damp-heat in the stomach and intestine, is matched with flos sophorae, fructus gardeniae, rhubarb root and herba violae to clear heat and calm the liver, cool blood and stop bleeding, and relieve swelling and detoxify, and is used as a ministerial drug; evodia rutaecarpa and aucklandia root, radix aucklandiae, as adjuvant drugs, have the effects of warming the middle-jiao to alleviate pain, regulating the flow of qi to arrest vomiting, halloysitum rubrum and pomegranate rind, relieving diarrhea with astringents, promoting granulation and healing wound. The further preferable mixture ratio of the raw materials is as follows: 29 to 34 parts of coptis chinensis, 25 to 27 parts of scutellaria baicalensis, 35 to 45 parts of rheum officinale, 35 to 45 parts of Chinese angelica, 30 to 34 parts of white paeony root, 18 to 20 parts of sophora japonica, 7 to 11 parts of gardenia, 13 to 15 parts of rheum officinale, 28 to 30 parts of Chinese violet, 17 to 20 parts of evodia rutaecarpa, 17 to 20 parts of costustoot, 15 to 17 parts of red halloysite and 12 to 16 parts of pomegranate bark. The further preferable mixture ratio is as follows: 32 parts of coptis chinensis, 26 parts of scutellaria baicalensis, 40 parts of rheum officinale, 40 parts of angelica sinensis, 32 parts of radix paeoniae alba, 19 parts of sophora flower, 9 parts of gardenia, 14 parts of rheum officinale, 29 parts of Chinese violet, 18 parts of fructus evodiae, 18 parts of elecampane, 16 parts of red halloysite and 14 parts of pomegranate bark.
In a second aspect, the embodiment of the invention also provides a suppository for preventing and treating canine parvovirus enteritis, and the active ingredients of the suppository comprise the traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis. The traditional Chinese medicine composition is prepared into suppository, so that rectal administration is more convenient.
In a third aspect, the embodiment of the invention also provides a preparation method of the suppository for preventing and treating canine parvoviral enteritis, which specifically comprises the following operations:
weighing the raw materials in the traditional Chinese medicine composition according to the weight part ratio, decocting the raw materials in water for extraction, concentrating the obtained extracting solution, and drying the extracting solution to prepare traditional Chinese medicine extract powder; melting semisynthetic fatty glyceride, adding the Chinese medicinal extract powder, mixing, and molding.
Wherein the operation of water decoction and extraction is preferably 1 to 3 times, 1.5 to 2h each time. The semisynthetic fatty glyceride can be selected from common semisynthetic fatty glyceride in suppository such as coconut oil ester, palm oil ester, pungent litse fruit oil ester or propylene glycol stearate.
In a fourth aspect, the embodiment of the invention also provides another preparation method of the suppository for preventing and treating canine parvoviral enteritis, which specifically comprises the following operations:
weighing the raw materials in the traditional Chinese medicine composition according to the weight part ratio, wherein the angelica is the Chinese angelica stir-fried with charcoal;
reflux-extracting the coptis chinensis by using 0.5% -1.0% v/v sulfuric acid aqueous solution to obtain an extracting solution and coptis chinensis residues, adjusting the pH of the extracting solution to 1-1.5 by using concentrated hydrochloric acid, filtering, washing the obtained filter cake to be neutral by using water, and drying to obtain a first coptis chinensis extract; placing the coptis chinensis residue in water, performing enzymolysis by using cellulase, filtering, concentrating the filtrate, and drying to obtain a second extract of coptis chinensis;
reflux-extracting the radix Angelicae sinensis with ethanol water solution, filtering, concentrating the filtrate, and drying to obtain radix Angelicae sinensis extract;
ultrasonically extracting the white paeony root with an ethanol water solution to obtain white paeony root ethanol extract and white paeony root residues, extracting the white paeony root residues with water under reflux to obtain white paeony root water extract, respectively concentrating and drying the white paeony root ethanol extract and the white paeony root water extract, and mixing to obtain a white paeony root extract;
reflux-extracting Scutellariae radix with acetic acid water solution to obtain Scutellariae radix acid extractive solution and Scutellariae radix residue, reflux-extracting Scutellariae radix residue with ethanol water solution to obtain Scutellariae radix ethanol extractive solution, concentrating and drying the Scutellariae radix acid extractive solution and Scutellariae radix ethanol extractive solution respectively, and mixing to obtain Scutellariae radix extract;
reflux-extracting the rhubarb with a sodium bicarbonate aqueous solution with the pH value of 7.5-8.0, concentrating and drying the obtained extract to obtain a rhubarb extract;
mixing the rest materials, extracting with water under reflux, concentrating the extractive solution, and drying to obtain mixed extract;
mixing the first extract of Coptidis rhizoma, the second extract of Coptidis rhizoma, the extract of Angelicae Gigantis radix, paeoniae alba, scutellariae radix, and radix et rhizoma Rhei with the mixed extract to obtain Chinese medicinal extract powder; melting semisynthetic fatty glyceride, adding the Chinese medicinal extract powder, mixing, and molding.
Preferably, the mass of the cellulase is 0.5% -1.5% of the mass of the coptis chinensis residue, the enzymolysis temperature is 35-45 ℃, and the enzymolysis time is 3-5h.
Preferably, the aqueous ethanol solution from which the angelica extract is prepared has a concentration of 50% to 60% v/v, the aqueous ethanol solution containing 1.5% to 3.5% m/m sodium chloride.
Preferably, the concentration of the aqueous ethanol solution for preparing the white peony root extract is 45% -60%, v/v, and the parameters of ultrasonic extraction are 45-50Hz, 240-250W.
Preferably, the concentration of said aqueous acetic acid solution for preparing said Scutellariae radix extract is 0.15% to 0.25% v/v, the concentration of said aqueous ethanol solution is 40% to 60% v/v.
The traditional Chinese medicine raw materials are extracted according to the method and then are prepared into suppository, so that the curative effect can be further improved, and the treatment effect on puppies is particularly remarkable.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is further described in detail with reference to the following embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
The canine parvoviral enteritis has acute onset and short course of disease, is mainly treated according to the illness condition, mainly corrects dehydration, is assisted by hyperimmune serotherapy, antibiotic treatment and the like, prevents secondary infection, is mostly treated by infusion, and has poor matching degree for sick dogs. Moreover, antibiotics can cause adverse reactions of different degrees, and particularly, the antibiotics are more obvious in body damage caused by puppies. The cured sick dogs also carry viruses continuously, and the viruses infect other dogs through excrement, urine, vomit and the like, so that the dogs are difficult to completely eliminate in a dog group once the dogs are infected with the viruses.
The traditional Chinese medicine considers that the disease is caused by damp-heat and steaming, heat-toxin stagnation, qi-blood stagnation, toxin stagnation in intestines, stagnation and blood stasis, and heat injury to blood system. Aiming at the adverse reaction caused by antibiotics, the traditional Chinese medicine is used for treating canine parvovirus enteritis in the prior art. The traditional Chinese medicine has the advantages of no drug residue, no hormone, no drug resistance, wide drug sources, local materials, low price, stable curative effect, small toxic and side effects and the like, and the traditional Chinese medicine formula with reasonable compatibility can resist bacteria, diminish inflammation, resist viruses and expel and kill parasites, and vitamins, mineral substances, trace elements, specific natural compounds and the like contained in the traditional Chinese medicine formula can provide nutrition for sick animals and improve the health condition of organisms. However, most of the treatments with traditional Chinese medicines have slow effect and uncertain curative effect, and most of the traditional Chinese medicines have poor smell, so that the administration is difficult and the intake can not be ensured.
In order to solve the problems of inconvenient administration, difficult administration and slow response, the embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvoviral enteritis, which comprises the following raw materials: coptis root, scutellaria baicalensis, rheum officinale, angelica sinensis, white paeony root, at least one of lotus plumule, sophora flower and gardenia, at least one of rheum officinale, picria fel-terrae lour, patrinia, chinese violet and cacumen biotae, at least one of perilla stem, fructus evodiae and costus root, and at least one of halloysite, gallnut and pomegranate rind. The traditional Chinese medicine composition is a traditional Chinese medicine formula which can exert curative effect through rectal administration, has the effects of clearing heat, activating blood circulation, stopping dysentery and collecting yin, is quick in effect taking, has no side effect, is very suitable for treating canine parvovirus enteritis, has excellent treatment and prevention effects on puppies, and has no adverse reaction.
The embodiment of the application provides a combination with an optimal proportion, which comprises the following raw materials in parts by weight: 27 to 36 parts of coptis chinensis, 20 to 29 parts of scutellaria baicalensis, 30 to 50 parts of rheum officinale, 30 to 50 parts of angelica, 28 to 37 parts of white paeony root, 10 to 15 parts of lotus plumule, 8 to 17 parts of gardenia, 10 to 17 parts of rheum officinale, 12 to 18 parts of herba patriniae, 40 to 60 parts of perilla stem and 20 to 30 parts of Chinese gall. The method comprises the following steps: the coptis root and the scutellaria root are used as monarch drugs for clearing heat, drying dampness, purging fire and removing toxin, and the angelica and the white paeony root are used for enriching the blood, nourishing the blood, astringing yin and relieving pain; rhubarb, radix et rhizoma Rhei purges heat and purges intestines, eliminates the stagnation of damp-heat in the stomach and intestine, is matched with lotus plumule, cape jasmine fruit, rhubarb and herba patriniae to clear heat and calm the liver, cool blood and stop bleeding, and is used as a ministerial drug; perilla stem is used as adjuvant drug for regulating qi-flowing and relieving pain, and Galla chinensis is used for astringing intestine to stop diarrhea, promoting granulation and healing sore. In the embodiment of the application, the further preferable mixture ratio of the raw materials is as follows: 30 to 33 parts of coptis chinensis, 23 to 26 parts of scutellaria baicalensis, 35 to 45 parts of rheum officinale, 35 to 45 parts of angelica sinensis, 31 to 35 parts of radix paeoniae alba, 11 to 13 parts of lotus plumule, 10 to 14 parts of gardenia, 12 to 15 parts of rheum officinale, 14 to 17 parts of herba patriniae, 45 to 55 parts of perilla stem and 22 to 27 parts of gallnut. The more preferable mixture ratio is: 31 parts of coptis chinensis, 25 parts of scutellaria baicalensis, 40 parts of rheum officinale, 40 parts of angelica sinensis, 33 parts of radix paeoniae alba, 12 parts of lotus plumule, 13 parts of gardenia, 13 parts of rheum officinale, 16 parts of herba patriniae, 50 parts of perilla stem and 25 parts of gallnut.
The embodiment of the application provides another combination with a preferable mixture ratio, which comprises the following raw materials in parts by weight: 27 to 36 parts of coptis chinensis, 20 to 29 parts of scutellaria baicalensis, 30 to 50 parts of rheum officinale, 30 to 50 parts of Chinese angelica, 28 to 37 parts of white paeony root, 25 to 32 parts of sophora japonica, 15 to 23 parts of picria felterrae lour, 5 to 12 parts of Chinese violet, 15 to 22 parts of cacumen biotae, 30 to 42 parts of elecampane and 18 to 22 parts of pomegranate bark. The method comprises the following steps: the coptis and the scutellaria clear heat and dry dampness, purge fire and remove toxin, and the angelica and the white paeony root enrich blood and nourish blood, astringe yin and relieve pain, which are monarch drugs; rhubarb, radix et rhizoma Rhei purges heat and purges intestines, eliminates the stagnation of damp-heat in the stomach and intestine, is matched with flos sophorae, picria felterrae lour, herba violae and cacumen biotae to cool blood and stop bleeding, clear heat and remove toxicity, and is used as a ministerial medicine; mu Xiang warms the middle-jiao to alleviate pain, and Shi Gu Pi astringes intestines to check diarrhea and prevent collapse is used as adjuvant drug. In the embodiment of the application, the further preferable mixture ratio of the raw materials is as follows: 30 to 33 parts of coptis chinensis, 23 to 26 parts of scutellaria baicalensis, 35 to 45 parts of rheum officinale, 35 to 45 parts of Chinese angelica, 31 to 35 parts of white paeony root, 27 to 30 parts of sophora japonica, 17 to 21 parts of picria felterrae lour, 7 to 10 parts of Chinese violet, 17 to 20 parts of cacumen biotae, 34 to 39 parts of elecampane and 19 to 21 parts of pomegranate rind. The more preferable mixture ratio is as follows: 32 parts of coptis root, 24 parts of scutellaria baicalensis, 40 parts of rhubarb, 40 parts of angelica, 33 parts of white peony root, 29 parts of sophora flower, 19 parts of picria felterrae lour, 8 parts of Chinese violet, 18 parts of cacumen biotae, 36 parts of elecampane and 20 parts of pomegranate bark.
The embodiment of the application provides another combination with a preferable mixture ratio, which comprises the following raw materials in parts by weight: 27 to 36 parts of coptis chinensis, 20 to 29 parts of scutellaria baicalensis, 30 to 50 parts of rheum officinale, 30 to 50 parts of angelica, 28 to 37 parts of radix paeoniae alba, 25 to 32 parts of sophora flower, 23 to 32 parts of herba patriniae, 16 to 23 parts of cacumen biotae, 30 to 38 parts of fructus evodiae and 18 to 22 parts of pomegranate bark. The method comprises the following steps: the coptis root and the scutellaria root are used as main medicines for clearing heat and drying dampness, purging fire and removing toxin, and the angelica and the white paeony root are used for enriching the blood and nourishing the blood, astringing yin and relieving pain; rhubarb, radix et rhizoma Rhei purges heat and purges intestines, eliminates the stagnation of damp-heat in the stomach and intestine, is matched with flos sophorae, herba patriniae and cacumen biotae to cool blood and stop bleeding, purge fire and detoxify as assistant drugs; evodia rutaecarpa and pomegranate rind act as adjuvant drugs for warming the middle-jiao to alleviate pain, regulating qi to arrest vomiting, astringing intestines to arrest diarrhea and preventing collapse. In the embodiment of the application, the further preferable mixture ratio of the raw materials is as follows: 30 to 34 parts of coptis chinensis, 22 to 26 parts of scutellaria baicalensis, 35 to 45 parts of rheum officinale, 35 to 45 parts of Chinese angelica, 30 to 34 parts of white paeony root, 26 to 30 parts of sophora japonica, 26 to 30 parts of herba patriniae, 18 to 22 parts of cacumen platycladi, 32 to 36 parts of fructus evodiae and 18 to 22 parts of pericarpium granati. The more preferable mixture ratio is: 32 parts of coptis chinensis, 24 parts of scutellaria baicalensis, 40 parts of rheum officinale, 40 parts of angelica sinensis, 32 parts of radix paeoniae alba, 28 parts of sophora flower, 28 parts of herba patriniae, 20 parts of cacumen biotae, 34 parts of fructus evodiae and 20 parts of pomegranate rind.
The embodiment of the application provides another combination with a preferable mixture ratio, which comprises the following raw materials in parts by weight: 27 to 36 parts of coptis chinensis, 20 to 29 parts of scutellaria baicalensis, 30 to 50 parts of rheum officinale, 30 to 50 parts of angelica, 28 to 37 parts of radix paeoniae alba, 16 to 22 parts of sophora japonica, 5 to 13 parts of gardenia, 12 to 16 parts of rheum officinale, 25 to 32 parts of philippine violet herb, 15 to 23 parts of evodia rutaecarpa, 15 to 23 parts of costustoot, 12 to 19 parts of red halloysite and 10 to 18 parts of pomegranate bark. The method comprises the following steps: the coptis and the scutellaria clear heat and dry dampness, purge fire and remove toxin, and the angelica and the white paeony root enrich blood and nourish blood, astringe yin and relieve pain, which are monarch drugs; rhubarb, radix et rhizoma Rhei purges heat and purges intestines, eliminates dampness-heat accumulation in stomach and intestine, is matched with flos Sophorae Immaturus, fructus Gardeniae, radix Rumicis, and herba Violae to clear heat and calm liver, cool blood and stop bleeding, and relieve swelling and remove toxicity, and is used as a ministerial drug; evodia rutaecarpa and aucklandia root, radix aucklandiae, as adjuvant drugs, have the effects of warming the middle-jiao to alleviate pain, regulating the flow of qi to arrest vomiting, halloysitum rubrum and pomegranate rind, relieving diarrhea with astringents, promoting granulation and healing wound. In the embodiment of the application, the further preferable mixture ratio of the raw materials is as follows: 29 to 34 parts of coptis chinensis, 25 to 27 parts of scutellaria baicalensis, 35 to 45 parts of rheum officinale, 35 to 45 parts of angelica, 30 to 34 parts of white paeony root, 18 to 20 parts of sophora flower, 7 to 11 parts of gardenia, 13 to 15 parts of rheum officinale, 28 to 30 parts of Chinese violet, 17 to 20 parts of evodia rutaecarpa, 17 to 20 parts of costustoot, 15 to 17 parts of red halloysite and 12 to 16 parts of pomegranate bark. The more preferable mixture ratio is: 32 parts of coptis chinensis, 26 parts of scutellaria baicalensis, 40 parts of rheum officinale, 40 parts of angelica sinensis, 32 parts of radix paeoniae alba, 19 parts of sophora flower, 9 parts of gardenia, 14 parts of rheum officinale, 29 parts of Chinese violet, 18 parts of fructus evodiae, 18 parts of elecampane, 16 parts of red halloysite and 14 parts of pomegranate bark.
In order to further facilitate clinical use, the embodiment of the invention provides a suppository for preventing and treating canine parvoviral enteritis, and the active ingredients of the suppository comprise the traditional Chinese medicine composition for preventing and treating canine parvoviral enteritis.
The medicinal materials are processed and extracted by different methods, and the property and the effect of the medicinal materials can be changed. Different processing and extracting methods also have different requirements on production conditions. The invention provides two preparation methods to prepare the suppository for preventing and treating canine parvovirus enteritis by combining clinical curative effect, production cost and feasibility.
The first preparation method specifically comprises the following operations:
weighing the raw materials in the traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis according to the weight part ratio, decocting and extracting the raw materials with water, concentrating the obtained extracting solution, and drying to prepare traditional Chinese medicine extract powder; melting semisynthetic fatty glyceride, adding the Chinese medicinal extract powder, mixing, and molding.
In the embodiment, the decoction can be carried out for 1 to 3 times, 1.5 to 2h each time. The semisynthetic fatty glyceride can be selected from semisynthetic fatty glyceride commonly used in suppository such as coconut oil ester, palm oil ester, pungent litse fruit oil ester or propylene glycol stearate.
The second preparation method specifically includes the following operations:
weighing the raw materials in the traditional Chinese medicine composition according to the weight part ratio, wherein the effect of the angelica is better when the angelica is fried by carbon;
reflux-extracting Coptidis rhizoma with 0.5% -1.0% v/v sulfuric acid aqueous solution to obtain extractive solution and Coptidis rhizoma residue, adjusting pH of the extractive solution with concentrated hydrochloric acid to 1 to 1.5, filtering, washing the obtained filter cake with water to neutrality, and drying to obtain Coptidis rhizoma first extract; placing the rhizoma Coptidis residue in water, performing enzymolysis with cellulase, filtering, concentrating the filtrate, and drying to obtain a second extract of rhizoma Coptidis;
reflux-extracting radix Angelicae sinensis (parched with charcoal) with ethanol water solution, filtering, concentrating the filtrate, and drying to obtain radix Angelicae sinensis extract;
ultrasonically extracting radix Paeoniae alba with ethanol water solution to obtain radix Paeoniae alba ethanol extractive solution and radix Paeoniae alba residue, extracting radix Paeoniae alba residue with water under reflux to obtain radix Paeoniae alba water extractive solution, concentrating the radix Paeoniae alba ethanol extractive solution and radix Paeoniae alba water extractive solution respectively, drying, and mixing to obtain radix Paeoniae alba extract;
reflux-extracting Scutellariae radix with acetic acid water solution to obtain Scutellariae radix acid extractive solution and Scutellariae radix residue, reflux-extracting Scutellariae radix residue with ethanol water solution to obtain Scutellariae radix ethanol extractive solution, concentrating Scutellariae radix acid extractive solution and Scutellariae radix ethanol extractive solution respectively, drying, and mixing to obtain Scutellariae radix extract;
reflux-extracting rhubarb with a sodium bicarbonate aqueous solution with the pH value of 7.5-8.0, concentrating the obtained extracting solution, and drying to obtain a rhubarb extract;
mixing the rest materials, extracting with water under reflux, concentrating the extractive solution, and drying to obtain mixed extract;
mixing the first extract of Coptidis rhizoma, the second extract of Coptidis rhizoma, the extract of radix Angelicae sinensis, the extract of radix Paeoniae alba, the extract of Scutellariae radix, the extract of radix et rhizoma Rhei and the mixed extract to obtain Chinese medicinal extract powder; melting semisynthetic fatty glyceride, adding the Chinese medicinal extract powder, mixing, and molding.
The suppository prepared by the preparation method has better curative effect than the suppository prepared by the first preparation method, and particularly has higher cure rate and faster effect on puppies.
In the embodiment, when the dosage of the cellulase is preferably 0.5-1.5% of the mass of the coptis chinensis residue, the enzymolysis temperature is 35-45 ℃, and the enzymolysis time is 3-5 hours; when the aqueous ethanol solution used to prepare the Angelica sinensis extract has a concentration of 50% -60% v/v, and contains 1.5% -3.5% m/m sodium chloride; when the concentration of the ethanol water solution for preparing the white peony root extract is 45% -60% v/v, the parameters of ultrasonic extraction are 45-50Hz, and 240-250W; or when the concentration of the aqueous acetic acid solution for preparing the Scutellariae radix extract is 0.15% to 0.25% v/v, the concentration of the aqueous ethanol solution is 40% to 60% v/v, the therapeutic effect can be further improved.
The following examples are provided to further illustrate the present invention in terms of several examples, and some comparative experiments and animal experiments are listed to verify the prevention and treatment effect of the present invention on canine parvoviral enteritis.
Example 1
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 31 parts of coptis chinensis, 25 parts of scutellaria baicalensis, 40 parts of rheum officinale, 40 parts of angelica sinensis, 33 parts of radix paeoniae alba, 12 parts of lotus plumule, 13 parts of gardenia, 13 parts of rheum officinale, 16 parts of herba patriniae, 50 parts of perilla stem and 25 parts of gallnut.
Example 2
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 30 parts of coptis chinensis, 23 parts of scutellaria baicalensis, 35 parts of rheum officinale, 35 parts of angelica sinensis, 31 parts of radix paeoniae alba, 11 parts of lotus plumule, 10 parts of gardenia, 12 parts of rheum officinale, 14 parts of herba patriniae, 45 parts of perilla stem and 22 parts of gallnut.
Example 3
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 33 parts of coptis chinensis, 26 parts of scutellaria baicalensis, 45 parts of rheum officinale, 45 parts of angelica sinensis, 35 parts of radix paeoniae alba, 13 parts of lotus plumule, 14 parts of gardenia, 15 parts of rheum officinale, 17 parts of herba patriniae, 55 parts of perilla stem and 27 parts of gallnut.
Example 4
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 27 parts of coptis chinensis, 20 parts of scutellaria baicalensis, 30 parts of rheum officinale, 30 parts of angelica sinensis, 28 parts of radix paeoniae alba, 10 parts of lotus plumule, 8 parts of gardenia, 10 parts of rheum officinale, 12 parts of herba patriniae, 40 parts of perilla stem and 20 parts of gallnut.
Example 5
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 36 parts of coptis chinensis, 29 parts of scutellaria baicalensis, 50 parts of rheum officinale, 50 parts of angelica sinensis, 37 parts of radix paeoniae alba, 15 parts of lotus plumule, 17 parts of gardenia, 17 parts of rheum officinale, 18 parts of herba patriniae, 60 parts of perilla stem and 30 parts of gallnut.
Example 6
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 32 parts of coptis chinensis, 24 parts of scutellaria baicalensis, 40 parts of rheum officinale, 40 parts of angelica sinensis, 33 parts of radix paeoniae alba, 29 parts of sophora flower, 19 parts of picria felterrae lour, 8 parts of Chinese violet, 18 parts of cacumen biotae, 36 parts of elecampane and 20 parts of pomegranate bark.
Example 7
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 30 parts of coptis chinensis, 23 parts of scutellaria baicalensis, 35 parts of rheum officinale, 35 parts of angelica sinensis, 31 parts of radix paeoniae alba, 27 parts of sophora flower, 17 parts of picria felterrae lour, 7 parts of Chinese violet, 17 parts of cacumen biotae, 34 parts of elecampane and 19 parts of pomegranate rind.
Example 8
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 33 parts of coptis chinensis, 26 parts of scutellaria baicalensis, 45 parts of rheum officinale, 45 parts of angelica sinensis, 35 parts of radix paeoniae alba, 30 parts of sophora flower, 21 parts of picria felterrae lour, 10 parts of philippine violet herb, 20 parts of cacumen biotae, 39 parts of elecampane and 21 parts of pomegranate bark.
Example 9
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 27 parts of coptis chinensis, 20 parts of scutellaria baicalensis, 30 parts of rheum officinale, 30 parts of angelica sinensis, 28 parts of radix paeoniae alba, 25 parts of sophora flower, 15 parts of picria felterrae lour, 5 parts of Chinese violet, 15 parts of cacumen biotae, 30 parts of elecampane and 18 parts of pomegranate bark.
Example 10
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 36 parts of coptis chinensis, 29 parts of scutellaria baicalensis, 50 parts of rheum officinale, 50 parts of angelica sinensis, 37 parts of radix paeoniae alba, 32 parts of sophora flower, 23 parts of picria felterrae lour, 12 parts of Chinese violet, 22 parts of cacumen biotae, 42 parts of elecampane and 22 parts of pomegranate bark.
Example 11
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 32 parts of coptis chinensis, 24 parts of scutellaria baicalensis, 40 parts of rheum officinale, 40 parts of angelica sinensis, 32 parts of radix paeoniae alba, 28 parts of sophora flower, 28 parts of herba patriniae, 20 parts of cacumen biotae, 34 parts of fructus evodiae and 20 parts of pomegranate rind.
Example 12
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 30 parts of coptis chinensis, 22 parts of scutellaria baicalensis, 35 parts of rheum officinale, 35 parts of angelica sinensis, 30 parts of radix paeoniae alba, 26 parts of sophora flower, 26 parts of patrinia, 18 parts of cacumen biotae, 32 parts of fructus evodiae and 18 parts of pomegranate rind.
Example 13
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 34 parts of coptis chinensis, 26 parts of scutellaria baicalensis, 45 parts of rheum officinale, 45 parts of angelica sinensis, 34 parts of radix paeoniae alba, 30 parts of sophora flower, 30 parts of patrinia, 22 parts of cacumen biotae, 36 parts of fructus evodiae and 22 parts of pomegranate rind.
Example 14
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 27 parts of coptis chinensis, 20 parts of scutellaria baicalensis, 30 parts of rheum officinale, 30 parts of angelica sinensis, 28 parts of radix paeoniae alba, 25 parts of sophora flower, 23 parts of herba patriniae, 16 parts of cacumen biotae, 30 parts of fructus evodiae and 18 parts of pomegranate bark.
Example 15
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 36 parts of coptis chinensis, 29 parts of scutellaria baicalensis, 50 parts of rheum officinale, 50 parts of angelica sinensis, 37 parts of radix paeoniae alba, 32 parts of sophora flower, 32 parts of herba patriniae, 23 parts of cacumen biotae, 38 parts of fructus evodiae and 22 parts of pomegranate bark.
Example 16
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 32 parts of coptis chinensis, 26 parts of scutellaria baicalensis, 40 parts of rheum officinale, 40 parts of angelica sinensis, 32 parts of radix paeoniae alba, 19 parts of sophora flower, 9 parts of gardenia, 14 parts of rheum officinale, 29 parts of Chinese violet, 18 parts of fructus evodiae, 18 parts of elecampane, 16 parts of red halloysite and 14 parts of pomegranate bark.
Example 17
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 29 parts of coptis root, 25 parts of scutellaria baicalensis, 35 parts of rhubarb, 35 parts of angelica, 30 parts of white peony root, 18 parts of sophora flower, 7 parts of gardenia, 13 parts of rhubarb root and rhizome, 28 parts of Chinese violet, 17 parts of evodia rutaecarpa, 17 parts of costustoot, 15 parts of red halloysite and 12 parts of pomegranate bark.
Example 18
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 34 parts of coptis chinensis, 27 parts of scutellaria baicalensis, 45 parts of rheum officinale, 45 parts of angelica sinensis, 34 parts of radix paeoniae alba, 20 parts of sophora japonica, 11 parts of gardenia, 15 parts of rheum officinale, 30 parts of Chinese violet, 20 parts of fructus evodiae, 20 parts of elecampane, 17 parts of red halloysite and 16 parts of pomegranate bark.
Example 19
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 27 parts of coptis chinensis, 20 parts of scutellaria baicalensis, 30 parts of rheum officinale, 30 parts of angelica sinensis, 28 parts of radix paeoniae alba, 16 parts of sophora flower, 5 parts of gardenia, 12 parts of rheum officinale, 25 parts of Chinese violet, 15 parts of fructus evodiae, 15 parts of elecampane, 12 parts of red halloysite and 10 parts of pomegranate bark.
Example 20
The embodiment of the invention provides a traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, which comprises the following raw materials: 36 parts of coptis chinensis, 29 parts of scutellaria baicalensis, 50 parts of rheum officinale, 50 parts of angelica sinensis, 37 parts of radix paeoniae alba, 22 parts of sophora flower, 13 parts of gardenia, 16 parts of rheum officinale, 32 parts of Chinese violet, 23 parts of fructus evodiae, 23 parts of elecampane, 19 parts of red halloysite and 18 parts of pomegranate bark.
Example 21
The embodiment of the invention provides a suppository for preventing and treating canine parvovirus enteritis, which comprises the traditional Chinese medicine composition of the embodiment 1 and coco oil.
The preparation method of the suppository comprises the following steps:
weighing the raw materials in the traditional Chinese medicine composition of the embodiment 1 according to the weight part ratio, adding water, decocting for 2 times, 2 hours for the first time and 1.5 hours for the 2 nd time, combining the decoctions, filtering, concentrating, spraying powder for later use. Heating coconut oil ester in 100 deg.C water bath to melt, adding the Chinese medicinal powder, stirring, molding, and making into suppository with length of about 2cm, height of about 0.85cm, and width of about 1cm, and drug content of 0.3g (calculated on crude drug) in each suppository.
Example 22
The embodiment of the invention provides a suppository for preventing and treating canine parvovirus enteritis, which comprises the traditional Chinese medicine composition of the embodiment 6 and coco oil.
The preparation method of the suppository comprises the following steps:
weighing the raw materials in the traditional Chinese medicine composition of the embodiment 6 according to the weight part ratio, adding water, decocting for 2 times, 2 hours for the first time and 1.5 hours for the 2 nd time, combining the decoctions, filtering, concentrating, spraying powder for later use. Heating coconut oil ester in 100 deg.C water bath to melt, adding the Chinese medicinal powder, stirring, molding, and making into suppository with length of about 2cm, height of about 0.85cm, and width of about 1cm, and drug content of 0.3g (calculated on crude drug) in each suppository.
Example 23
The embodiment of the invention provides a suppository for preventing and treating canine parvovirus enteritis, which comprises the traditional Chinese medicine composition of the embodiment 11 and coco oil.
The preparation method of the suppository comprises the following steps:
weighing the raw materials in the traditional Chinese medicine composition of the embodiment 11 according to the weight part ratio, adding water, decocting for 2 times, 2 hours for the first time and 1.5 hours for the 2 nd time, combining the decoctions, filtering, concentrating and spraying powder for later use. Heating coconut oil ester in 100 deg.C water bath to melt, adding the Chinese medicinal powder, stirring, molding, and making into suppository with length of about 2cm, height of about 0.85cm, and width of about 1cm, and drug content of 0.3g (calculated on crude drug) in each suppository.
Example 24
The embodiment of the invention provides a suppository for preventing and treating canine parvovirus enteritis, which comprises the traditional Chinese medicine composition in the embodiment 16 and coco oil.
The preparation method of the suppository comprises the following steps:
weighing the raw materials in the traditional Chinese medicine composition of the embodiment 16 according to the weight part ratio, adding water, decocting for 2 times, 2 hours for the first time and 1.5 hours for the 2 nd time, combining the decoctions, filtering, concentrating, spraying powder for later use. Heating coconut oil ester in 100 deg.C water bath to melt, adding the Chinese medicinal powder, stirring, molding, and making into suppository with length of about 2cm, height of about 0.85cm, and width of about 1cm, and drug content of 0.3g (calculated on crude drug) in each suppository.
Example 25
The embodiment of the invention provides a suppository for preventing and treating canine parvovirus enteritis, which comprises the traditional Chinese medicine composition in the embodiment 1 and coco oil.
The preparation method of the suppository comprises the following steps:
weighing the raw materials in the traditional Chinese medicine composition in the embodiment 1 according to the weight part ratio, wherein the angelica sinensis is stir-fried with charcoal;
reflux-extracting Coptidis rhizoma with 7 times of 0.75% (v/v) sulfuric acid aqueous solution to obtain extractive solution and Coptidis rhizoma residue, adjusting pH of the extractive solution to 1.2 with concentrated hydrochloric acid, filtering, washing the obtained filter cake with water to pH7, and drying to obtain first extract of Coptidis rhizoma; putting the coptis chinensis dregs in 6 times of water, performing enzymolysis for 4 hours at 35-45 ℃ by using cellulase accounting for 1.0% of the mass of the coptis chinensis dregs, heating to 90-95 ℃, keeping for 10 minutes to inactivate the enzyme, filtering, concentrating the filtrate at 45-55 ℃, and drying to obtain a second coptis chinensis extract;
reflux-extracting radix Angelicae sinensis with 8 times of 55% v/v ethanol water solution containing 2.5% m/m sodium chloride, filtering, concentrating the filtrate at 45-55 deg.C, and drying to obtain radix Angelicae sinensis extract;
ultrasonically extracting radix Paeoniae alba with 8 times of 55 v/v ethanol aqueous solution for 1h,45Hz and 240W to obtain radix Paeoniae alba ethanol extractive solution and radix Paeoniae alba residue, reflux-extracting radix Paeoniae alba residue with 5 times of water for 1.5h to obtain radix Paeoniae alba water extractive solution, concentrating the radix Paeoniae alba ethanol extractive solution and radix Paeoniae alba water extractive solution at 45-55 deg.C, drying, and mixing to obtain radix Paeoniae alba extract;
reflux-extracting Scutellariae radix with 6 times of 0.2% v/v acetic acid water solution for 1.5 hr to obtain Scutellariae radix acid extractive solution and Scutellariae radix residue, reflux-extracting Scutellariae radix residue with 6 times of 50% v/v ethanol water solution for 1.5 hr to obtain Scutellariae radix ethanol extractive solution, concentrating Scutellariae radix acid extractive solution and Scutellariae radix ethanol extractive solution at 45-55 deg.C respectively, drying, and mixing to obtain Scutellariae radix extract;
reflux-extracting radix et rhizoma Rhei with 7 times of sodium bicarbonate water solution of pH7.8 for 1.5h, concentrating the obtained extractive solution at 45-55 deg.C, and drying to obtain radix et rhizoma Rhei extract;
mixing the rest raw materials, performing reflux extraction by using water of which the amount is 7 times that of the mixture, concentrating the obtained extracting solution at 45 to 55 ℃, and drying to obtain a mixed extract;
mixing the first extract of Coptidis rhizoma, the second extract of Coptidis rhizoma, the extract of radix Angelicae sinensis, the extract of radix Paeoniae alba, the extract of Scutellariae radix, the extract of radix et rhizoma Rhei and the mixed extract to obtain Chinese medicinal extract powder; melting coconut oil ester, adding the Chinese medicinal extract powder, mixing, molding, and making into suppository with length of about 2cm, height of about 0.85cm, and width of about 1cm, and drug content of 0.3g (calculated on crude drug) in each suppository.
Example 26
The embodiment of the invention provides a suppository for preventing and treating canine parvovirus enteritis, which comprises the traditional Chinese medicine composition prepared in the embodiment 1 and coco oil.
The preparation method of the suppository comprises the following steps:
weighing the raw materials in the traditional Chinese medicine composition in the embodiment 1 according to the weight part ratio, wherein the angelica sinensis is stir-fried with charcoal;
reflux-extracting Coptidis rhizoma with 7 times of 0.5% v/v sulfuric acid aqueous solution to obtain extractive solution and Coptidis rhizoma residue, adjusting pH of the extractive solution to 1 with concentrated hydrochloric acid, filtering, washing the filter cake with water to pH7, and drying to obtain Coptidis rhizoma first extract; putting the coptis chinensis dregs in 7 times of water, performing enzymolysis for 5 hours at 35-45 ℃ by using cellulase accounting for 0.5% of the mass of the coptis chinensis dregs, heating to 90-95 ℃, keeping for 10 minutes to inactivate the enzyme, filtering, concentrating the filtrate at 45-55 ℃, and drying to obtain a second coptis chinensis extract;
reflux-extracting radix Angelicae sinensis with 8 times of 50% v/v ethanol water solution containing 1.5% m/m sodium chloride, filtering, concentrating the filtrate at 45-55 deg.C, and drying to obtain radix Angelicae sinensis extract;
ultrasonically extracting radix paeoniae alba by using 8 times of 45% v/v ethanol aqueous solution for 1h,45Hz and 240W to obtain radix paeoniae alba ethanol extract and radix paeoniae alba residues, refluxing and extracting the radix paeoniae alba residues by using 5 times of water for 1.2h to obtain radix paeoniae alba water extract, concentrating and drying the radix paeoniae alba ethanol extract and the radix paeoniae alba water extract at 45-55 ℃, and mixing to obtain the radix paeoniae alba extract;
reflux-extracting Scutellariae radix with 6 times of 0.15% m/m acetic acid water solution for 2h to obtain Scutellariae radix acid extractive solution and Scutellariae radix residue, reflux-extracting Scutellariae radix residue with 6 times of 40% v/v ethanol water solution for 2h to obtain Scutellariae radix ethanol extractive solution, concentrating Scutellariae radix acid extractive solution and Scutellariae radix ethanol extractive solution at 45 deg.C to 55 deg.C, drying, and mixing to obtain Scutellariae radix extract;
reflux-extracting radix et rhizoma Rhei with 8 times of sodium bicarbonate water solution of pH7.5 for 2 hr, concentrating the obtained extractive solution at 45-55 deg.C, and drying to obtain radix et rhizoma Rhei extract;
mixing the rest raw materials, performing reflux extraction by using 8 times of water, concentrating the obtained extracting solution at 45 to 55 ℃, and drying to obtain a mixed extract;
mixing the first extract of Coptidis rhizoma, the second extract of Coptidis rhizoma, the extract of radix Angelicae sinensis, the extract of radix Paeoniae alba, the extract of Scutellariae radix, the extract of radix et rhizoma Rhei and the mixed extract to obtain Chinese medicinal extract powder; melting coconut oil ester, adding the Chinese medicinal extract powder, mixing, molding, and making into suppository with length of about 2cm, height of about 0.85cm, and width of about 1cm, and drug content of 0.3g (calculated on crude drug) in each suppository.
Example 27
The embodiment of the invention provides a suppository for preventing and treating canine parvovirus enteritis, which comprises the traditional Chinese medicine composition prepared in the embodiment 1 and coco oil.
The preparation method of the suppository comprises the following steps:
weighing the raw materials in the traditional Chinese medicine composition in the embodiment 1 according to the weight part ratio, wherein the angelica sinensis is stir-fried with charcoal;
reflux-extracting Coptidis rhizoma with 7 times of 1.0 v/v sulfuric acid aqueous solution to obtain extractive solution and Coptidis rhizoma residue, adjusting pH of the extractive solution to 1.5 with concentrated hydrochloric acid, filtering, washing the filter cake with water to pH7, and drying to obtain Coptidis rhizoma first extract; putting the coptis chinensis residues into water with the amount of 5 times that of the coptis chinensis residues, performing enzymolysis for 3 hours at 35-45 ℃ by using cellulase with the mass being 1.5% of that of the coptis chinensis residues, heating to 90-95 ℃, keeping for 10 minutes to inactivate the enzyme, filtering, concentrating the filtrate at 45-55 ℃, and drying to obtain a second coptis chinensis extract;
reflux-extracting radix Angelicae sinensis with 8 times of 60% v/v ethanol water solution containing 3.5% m/m sodium chloride, filtering, concentrating the filtrate at 45-55 deg.C, and drying to obtain radix Angelicae sinensis extract;
ultrasonically extracting radix Paeoniae alba with 8 times of 60 v/v ethanol aqueous solution for 1h,50Hz and 250W to obtain radix Paeoniae alba ethanol extractive solution and radix Paeoniae alba residue, reflux-extracting radix Paeoniae alba residue with 5 times of water for 1.5h to obtain radix Paeoniae alba water extractive solution, concentrating the radix Paeoniae alba ethanol extractive solution and radix Paeoniae alba water extractive solution at 45-55 deg.C, drying, and mixing to obtain radix Paeoniae alba extract;
reflux-extracting Scutellariae radix with 6 times of 0.25% (v/v) acetic acid water solution for 1.5 hr to obtain Scutellariae radix acid extractive solution and Scutellariae radix residue, reflux-extracting Scutellariae radix residue with 6 times of 60% (v/v) ethanol water solution for 1.5 hr to obtain Scutellariae radix ethanol extractive solution, concentrating Scutellariae radix acid extractive solution and Scutellariae radix ethanol extractive solution at 45-55 deg.C respectively, drying, and mixing to obtain Scutellariae radix extract;
reflux-extracting radix et rhizoma Rhei with 7 times of sodium bicarbonate water solution of pH8.0 for 1.5 hr, concentrating the obtained extractive solution at 45-55 deg.C, and drying to obtain radix et rhizoma Rhei extract;
mixing the rest raw materials, performing reflux extraction by using water of which the amount is 7 times that of the mixture, concentrating the obtained extracting solution at 45 to 55 ℃, and drying to obtain a mixed extract;
mixing the first extract of Coptidis rhizoma, the second extract of Coptidis rhizoma, the extract of Angelicae Gigantis radix, radix Paeoniae alba, scutellariae radix, and radix et rhizoma Rhei, and the mixed extract, and making into Chinese medicinal extract powder; melting coconut oil ester, adding the Chinese medicinal extract powder, mixing, molding, and making into suppository with length of about 2cm, height of about 0.85cm, and width of about 1cm, and drug content of 0.3g (calculated on crude drug) per suppository.
Example 28
The embodiment of the invention provides a suppository for preventing and treating canine parvovirus enteritis, which comprises the traditional Chinese medicine composition in the embodiment 6 and coco oil. The preparation method and specification of the suppository are the same as those of example 25.
Example 29
The embodiment of the invention provides a suppository for preventing and treating canine parvovirus enteritis, which comprises the traditional Chinese medicine composition in the embodiment 6 and coco oil. The preparation method and specification of the suppository are the same as those of example 26.
Example 30
The embodiment of the invention provides a suppository for preventing and treating canine parvovirus enteritis, which comprises the traditional Chinese medicine composition in the embodiment 6 and coco oil. The suppository is prepared by the same method and specification as example 27.
Example 31
The embodiment of the invention provides a suppository for preventing and treating canine parvovirus enteritis, which comprises the traditional Chinese medicine composition in the embodiment 11 and coco oil. The preparation method and specification of the suppository are the same as those of example 25.
Example 32
The embodiment of the invention provides a suppository for preventing and treating canine parvovirus enteritis, which comprises the traditional Chinese medicine composition in the embodiment 11 and coco oil. The suppository is prepared by the same method and specification as example 26.
Example 33
The embodiment of the invention provides a suppository for preventing and treating canine parvovirus enteritis, which comprises the traditional Chinese medicine composition in the embodiment 11 and coco oil. The suppository is prepared by the same method and specification as example 27.
Example 34
The embodiment of the invention provides a suppository for preventing and treating canine parvovirus enteritis, which comprises the traditional Chinese medicine composition in the embodiment 16 and coco oil. The preparation method and specification of the suppository are the same as those of example 25.
Example 35
The embodiment of the invention provides a suppository for preventing and treating canine parvovirus enteritis, which comprises the traditional Chinese medicine composition of the embodiment 16 and coco oil. The preparation method and specification of the suppository are the same as those of example 26.
Example 36
The embodiment of the invention provides a suppository for preventing and treating canine parvovirus enteritis, which comprises the traditional Chinese medicine composition of the embodiment 16 and coco oil. The preparation method and specification of the suppository are the same as those of example 27.
Comparative example 1
The present comparative example provides a suppository, the raw materials of which are a traditional Chinese medicine composition and coconut oil ester, the traditional Chinese medicine composition is based on example 1, and coptis chinensis and scutellaria baicalensis are changed into phellodendron. The method specifically comprises the following raw materials: 56 parts of phellodendron, 40 parts of rhubarb, 40 parts of angelica, 33 parts of white peony root, 12 parts of lotus plumule, 13 parts of gardenia, 13 parts of rhubarb, 16 parts of herba patriniae, 50 parts of perilla stem and 25 parts of gallnut.
The preparation method and specifications were the same as in example 25.
Comparative example 2
The present comparative example provides a suppository, the raw materials of which are a traditional Chinese medicine composition and coconut oil ester, the traditional Chinese medicine composition is based on example 6, and coptis chinensis and scutellaria baicalensis are changed into phellodendron. The method specifically comprises the following raw materials: 56 parts of phellodendron, 40 parts of rhubarb, 40 parts of angelica, 33 parts of white peony root, 29 parts of sophora flower, 19 parts of picria felterrae lour, 8 parts of Chinese violet, 18 parts of cacumen biotae, 36 parts of costus root and 20 parts of pomegranate bark.
The preparation method and the specification are the same as those of example 25.
Comparative example 3
The present comparative example provides a suppository, the raw materials of which are a traditional Chinese medicine composition and coconut oil ester, the traditional Chinese medicine composition is based on example 11, and coptis chinensis and scutellaria baicalensis are changed into phellodendron. The method specifically comprises the following raw materials: 56 parts of phellodendron, 40 parts of rhubarb, 40 parts of angelica, 32 parts of white peony root, 28 parts of sophora flower, 28 parts of herba patriniae, 20 parts of cacumen biotae, 34 parts of fructus evodiae and 20 parts of pomegranate bark.
The preparation method and specifications were the same as in example 25.
Comparative example 4
The present comparative example provides a suppository, the raw materials of which are a traditional Chinese medicine composition and coconut oil ester, the traditional Chinese medicine composition is based on example 16, and coptis chinensis and scutellaria baicalensis are changed into phellodendron. The preparation method specifically comprises the following raw materials: 58 parts of phellodendron bark, 40 parts of rhubarb, 40 parts of angelica, 32 parts of white peony root, 19 parts of sophora flower, 9 parts of gardenia, 14 parts of rhubarb root, 29 parts of Chinese violet, 18 parts of evodia fruit, 18 parts of costus root, 16 parts of red halloysite and 14 parts of pomegranate rind.
The preparation method and specifications were the same as in example 25.
Comparative example 5
The present comparative example provides a suppository, the raw materials of which are a traditional Chinese medicine composition and coconut oil ester, the traditional Chinese medicine composition is based on example 1, and rheum officinale is changed into senna leaves. The method specifically comprises the following raw materials: 31 parts of coptis chinensis, 25 parts of scutellaria baicalensis, 40 parts of senna leaves, 40 parts of angelica sinensis, 33 parts of white paeony root, 12 parts of lotus plumule, 13 parts of gardenia, 13 parts of rhubarb root and rhizome, 16 parts of herba patriniae, 50 parts of perilla stem and 25 parts of Chinese gall.
The preparation method and specifications were the same as in example 25.
Comparative example 6
The present comparative example provides a suppository, the raw materials of which are a traditional Chinese medicine composition and coconut oil ester, the traditional Chinese medicine composition is based on example 6, and rheum officinale is changed into senna leaves. The preparation method specifically comprises the following raw materials: 32 parts of coptis chinensis, 24 parts of scutellaria baicalensis, 40 parts of senna leaves, 40 parts of angelica sinensis, 33 parts of white paeony root, 29 parts of sophora flower, 19 parts of picria felterrae lour, 8 parts of Chinese violet, 18 parts of cacumen biotae, 36 parts of costus root and 20 parts of pomegranate bark.
The preparation method and the specification are the same as those of example 25.
Comparative example 7
The present comparative example provides a suppository, the raw materials of which are a traditional Chinese medicine composition and coconut oil ester, the traditional Chinese medicine composition is based on example 11, and rheum officinale is changed into senna leaves. The method specifically comprises the following raw materials: 32 parts of coptis chinensis, 24 parts of scutellaria baicalensis, 40 parts of folium sennae, 40 parts of angelica sinensis, 32 parts of radix paeoniae alba, 28 parts of flos sophorae, 28 parts of herba patriniae, 20 parts of cacumen biotae, 34 parts of fructus evodiae and 20 parts of pomegranate rind.
The preparation method and specifications were the same as in example 25.
Comparative example 8
The present comparative example provides a suppository, the raw materials of which are a traditional Chinese medicine composition and coconut oil ester, the traditional Chinese medicine composition is based on example 16, and rheum officinale is changed into senna leaves. The preparation method specifically comprises the following raw materials: 32 parts of coptis chinensis, 26 parts of scutellaria baicalensis, 40 parts of folium sennae, 40 parts of angelica sinensis, 32 parts of radix paeoniae alba, 19 parts of sophora flower, 9 parts of gardenia, 14 parts of rheum officinale, 29 parts of Chinese violet, 18 parts of fructus evodiae, 18 parts of elecampane, 16 parts of red halloysite and 14 parts of pomegranate bark.
The preparation method and the specification are the same as those of example 25.
Effect example 1
A plurality of sick dogs and experimental dogs (all small dogs, and all dogs are small dogs of 12 months old or less and all are canine parvovirus enteritis diagnosed by diagnosis) which are harvested in animal hospitals from 2019 to 2021 in 6 months are selected, and the clinical manifestations of the sick dogs and the experimental dogs are diarrhea, vomiting and the like in different degrees.
The above disease dogs were divided into 17 groups, and the breed distribution of disease dogs with the same infection degree in each group was the same (for example, each group of severely infected disease dogs were 2 bomei dogs, 2 coxy dogs, 2 teddy dogs, and 2 barger dogs), and the breed was hermaphrodite and hermaphrodite in each group, and the age of the month was similar. The dogs in each group were treated with the suppositories obtained in examples 21, 22, 23, 24, 25, 28, 31 and 34 and comparative examples 1 to 8. The rectal administration was performed 1 time, one at a time, after defecation in the morning dogs. Blank control group was given one blank suppository. The blank suppository is prepared by the same method only by using the same matrix without adding traditional Chinese medicines. The same dog food is normally fed during the administration period, and the water is freely drunk.
The above dogs are respectively in different infection degrees, and the clinical characteristics are respectively as follows:
mild: a little depression, reduced appetite, excessive lying and less movement, vomiting and diarrhea, vomitus which is chyme and yellow gastric juice, thick excrement, stink and less urine, and the body temperature is 40 to 41 ℃ or normal;
medium: the appetite is exhausted, vomit is yellow or green mucus-like, or only vomit action is performed without vomit, the body temperature is not high or is higher than 40 ℃ for a long time, the excrement is thin-like, intestinal mucosa fragments or bubbles fallen off by mixed oil have special fishy smell, some are jet-shaped, and the tail part is full of fishy smell and thin stool; a decrease in urine volume; the wool is rough and messy and has no luster;
and (2) the severity: intractable vomiting and diarrhea, some of gastrointestinal hemorrhage, thready and weak pulse of medial femoral artery, cold palpation, body temperature drop, high collapse and exhaustion, lethargy, deep breathing, deep pit, severe dehydration, dull eyes, dry and cracked rhinoscope, poor skin elasticity, emaciation, protruded ribs, walking swing, dirty back hair, scanty urine and yellow color.
Clinical symptoms of the above dogs were counted for 7 days from the day of administration (0 d), and clinical treatment effects were counted according to the following criteria:
the effect is shown: the body temperature, diet, defecation and heart rate of the light and moderate sick dogs are recovered to be normal within 3d after treatment, and vomiting phenomenon does not occur; after the severe disease dog is treated, the body temperature is raised to 40 ℃ or the body temperature is low, the heart rate is reduced to below 140 times/min, the spirit is gradually recovered, a little food can be eaten, the excrement is gradually recovered to be normal, the vomiting symptom is gradually reduced, and the body temperature is recovered to be normal after the severe disease dog is treated for 3 days;
the method has the following advantages: after the light and medium sick dogs are treated, the body temperature, diet, defecation and heart rate are recovered to be normal within 6 days, and the vomiting phenomenon is avoided; after the severe disease dog is treated, the body temperature drops by more than 1 ℃, the heart rate drops to below 150 times/min, the spirit is gradually recovered, the excrement is gradually recovered, the vomiting symptom is gradually reduced, and the body temperature is recovered after the severe disease dog is treated for 6 days;
and (4) invalidation: no improvement in clinical symptoms or death of the sick dog.
The statistical results of the treatment effect are shown in table 1.
Wherein, the total effective rate = (number of effective cases + number of effective cases)/n × 100%.
TABLE 1 comparison of the therapeutic effects of the groups
The statistical results show that the canine parvovirus enteritis in each example group has higher total effective rate, which is obviously higher than that of a blank control group and than that of each comparative example group, wherein the total effective rate of the example 23 group, the example 31 group and the example 34 group is the highest, and the suppository obtained in the example of the invention has effective treatment effect on canine parvovirus, and the treatment effect of the example 23 group, the example 31 group and the example 34 group is the most obvious.
The traditional Chinese medicine compositions in the examples 2 to 5, 7 to 10, 12 to 15 and 17 to 20 and palm oil ester, litsea cubeba oil ester or propylene glycol stearate are taken as substrates, and the suppository prepared by the preparation method can be prepared into suppositories with the same specification for a small number of cases, and the total effective rate can reach more than 75 percent.
Effect example 2
Three canine farms with canine parvovirus infection cases were selected and fed small, medium and large dogs, respectively. Puppies (males and females) not infected with canine parvovirus and having an age of 4 months or less were administered with the suppositories obtained in examples 21, 22, 23, 24, 25, 28, 31, and 34 and comparative examples 1 to 8, respectively, for prevention. The rectal administration was performed 1 time, one at a time, after defecation in the morning dogs. Blank control group was given one blank suppository. The blank suppository is prepared by the same method only by using the same matrix without adding traditional Chinese medicines. The same dog food was fed normally during dosing, with free access to water.
The number of infections of the puppies within 14d from the day of medication (0 d) is counted, and the results are shown in tables 2 to 4:
TABLE 2 statistics of preventive effect (small dog farm)
Group of | n | Number of infected cases |
Example 21 | 50 | 7 |
Example 22 | 50 | 5 |
Example 23 | 50 | 2 |
Example 24 | 50 | 4 |
Example 25 | 50 | 5 |
Example 28 | 50 | 4 |
Example 31 | 50 | 0 |
Example 34 | 50 | 3 |
Comparative example 1 | 50 | 19 |
Comparative example 2 | 50 | 16 |
Comparative example 3 | 50 | 14 |
Comparative example 4 | 50 | 17 |
Comparative example 5 | 50 | 16 |
Comparative example 6 | 50 | 14 |
Comparative example 7 | 50 | 11 |
Comparative example 8 | 50 | 15 |
Blank control group | 50 | 38 |
TABLE 3 statistics of preventive effect (Medium dog farm)
Group of | n | Number of infected cases |
Example 21 | 50 | 6 |
Example 22 | 50 | 6 |
Example 23 | 50 | 3 |
Example 24 | 50 | 5 |
Example 25 | 50 | 4 |
Example 28 | 50 | 3 |
Example 31 | 50 | 0 |
Example 34 | 50 | 3 |
Comparative example 1 | 50 | 18 |
Comparative example 2 | 50 | 17 |
Comparative example 3 | 50 | 15 |
Comparative example 4 | 50 | 17 |
Comparative example 5 | 50 | 15 |
Comparative example 6 | 50 | 15 |
Comparative example 7 | 50 | 11 |
Comparative example 8 | 50 | 14 |
Blank control group | 50 | 35 |
TABLE 4 statistics of preventive effect (Large dog farm)
Group of | n | Number of infected cases |
Example 21 | 50 | 6 |
Example 22 | 50 | 5 |
Example 23 | 50 | 2 |
Practice ofExample 24 | 50 | 5 |
Example 25 | 50 | 4 |
Example 28 | 50 | 3 |
Example 31 | 50 | 0 |
Example 34 | 50 | 4 |
Comparative example 1 | 50 | 18 |
Comparative example 2 | 50 | 16 |
Comparative example 3 | 50 | 13 |
Comparative example 4 | 50 | 15 |
Comparative example 5 | 50 | 16 |
Comparative example 6 | 50 | 13 |
Comparative example 7 | 50 | 11 |
Comparative example 8 | 50 | 14 |
Blank control group | 50 | 33 |
According to the statistical results, the infection rates of the example groups are 0 to 14 percent and are obviously lower than those of the blank control group and than those of the comparative example groups, wherein the infection rates of the example 23 group and the example 31 group are the lowest, and the suppository obtained in the example of the invention is proved to have excellent prevention effect on canine parvovirus, and the prevention effect of the example 23 and the example 31 is the most obvious.
A small number of cases were examined by using the Chinese medicinal compositions of examples 2 to 5, 7 to 10, 12 to 15, and 17 to 20 and palm oil ester, pungent litse fruit oil ester, or propylene glycol stearate as bases, and preparing suppositories of the same specification by the above-mentioned preparation method, wherein the infection rate was 15% or less.
The above description is intended to be illustrative of the preferred embodiment of the present invention and should not be taken as limiting the invention, but rather, the invention is intended to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention.
Claims (9)
1. The traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis is characterized by comprising the following raw materials in parts by weight: 27 to 36 parts of coptis chinensis, 20 to 29 parts of scutellaria baicalensis, 30 to 50 parts of rheum officinale, 30 to 50 parts of angelica sinensis, 28 to 37 parts of white paeony root, 10 to 15 parts of lotus plumule, 8 to 17 parts of gardenia, 10 to 17 parts of rheum officinale, 12 to 18 parts of patrinia scaniosaefolia, 40 to 60 parts of perilla stem and 20 to 30 parts of gallnut.
2. The traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis is characterized by comprising the following raw materials in parts by weight: 27 to 36 parts of coptis chinensis, 20 to 29 parts of scutellaria baicalensis, 30 to 50 parts of rheum officinale, 30 to 50 parts of angelica, 28 to 37 parts of white paeony root, 25 to 32 parts of sophora flower, 15 to 23 parts of picria felterrae lour, 5 to 12 parts of Chinese violet, 15 to 22 parts of cacumen biotae, 30 to 42 parts of costustoot and 18 to 22 parts of pomegranate bark.
3. The traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis is characterized by comprising the following raw materials in parts by weight: 27 to 36 parts of coptis chinensis, 20 to 29 parts of scutellaria baicalensis, 30 to 50 parts of rheum officinale, 30 to 50 parts of angelica, 28 to 37 parts of radix paeoniae alba, 25 to 32 parts of sophora flower, 23 to 32 parts of herba patriniae, 16 to 23 parts of cacumen biotae, 30 to 38 parts of fructus evodiae and 18 to 22 parts of pomegranate bark.
4. The traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis is characterized by comprising the following raw materials in parts by weight: 27 to 36 parts of coptis chinensis, 20 to 29 parts of scutellaria baicalensis, 30 to 50 parts of rheum officinale, 30 to 50 parts of Chinese angelica, 28 to 37 parts of white paeony root, 16 to 22 parts of sophora japonica, 5 to 13 parts of gardenia, 12 to 16 parts of rheum officinale, 25 to 32 parts of Chinese violet, 15 to 23 parts of evodia rutaecarpa, 15 to 23 parts of costustoot, 12 to 19 parts of red halloysite and 10 to 18 parts of pomegranate bark.
5. A suppository for preventing and treating canine parvoviral enteritis, which is characterized in that the active ingredient of the suppository is the traditional Chinese medicine composition for preventing and treating canine parvoviral enteritis according to any one of claims 1 to 4.
6. A preparation method of a suppository for preventing and treating canine parvovirus enteritis is characterized by comprising the following operations:
weighing the raw materials in the traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis according to any one of claims 1 to 4 in parts by weight, decocting the raw materials with water for extraction, concentrating the obtained extract, drying, and preparing the concentrated extract into traditional Chinese medicine extract powder; melting semisynthetic fatty glyceride, adding the Chinese medicinal extract powder, mixing, and molding.
7. A preparation method of a suppository for preventing and treating canine parvovirus enteritis is characterized by comprising the following steps:
weighing the raw materials in the traditional Chinese medicine composition according to any one of claims 1 to 4 in parts by weight, wherein the angelica is carbon-fried angelica;
reflux-extracting the coptis chinensis by using 0.5% -1.0% v/v sulfuric acid aqueous solution to obtain an extracting solution and coptis chinensis residues, adjusting the pH of the extracting solution to 1-1.5 by using concentrated hydrochloric acid, filtering, washing the obtained filter cake to be neutral by using water, and drying to obtain a first coptis chinensis extract; placing the coptis chinensis residue in water, performing enzymolysis by using cellulase, filtering, concentrating the filtrate, and drying to obtain a second extract of coptis chinensis;
extracting radix Angelicae sinensis with ethanol water under reflux, filtering, concentrating the filtrate, and drying to obtain radix Angelicae sinensis extract;
ultrasonically extracting the white paeony root with an ethanol water solution to obtain white paeony root ethanol extract and white paeony root residues, extracting the white paeony root residues with water under reflux to obtain white paeony root water extract, respectively concentrating and drying the white paeony root ethanol extract and the white paeony root water extract, and mixing to obtain a white paeony root extract;
reflux-extracting Scutellariae radix with acetic acid water solution to obtain Scutellariae radix acid extractive solution and Scutellariae radix residue, reflux-extracting Scutellariae radix residue with ethanol water solution to obtain Scutellariae radix ethanol extractive solution, concentrating and drying the Scutellariae radix acid extractive solution and Scutellariae radix ethanol extractive solution respectively, and mixing to obtain Scutellariae radix extract;
reflux-extracting the rhubarb with a sodium bicarbonate aqueous solution with the pH value of 7.5-8.0, concentrating and drying the obtained extracting solution to obtain a rhubarb extract;
mixing the rest raw materials, extracting with water under reflux, concentrating the extractive solution, and drying to obtain mixed extract;
mixing the first extract of Coptidis rhizoma, the second extract of Coptidis rhizoma, the extract of Angelicae Gigantis radix, paeoniae alba, scutellariae radix, and radix et rhizoma Rhei with the mixed extract to obtain Chinese medicinal extract powder; melting semisynthetic fatty glyceride, adding the Chinese medicinal extract powder, mixing, and injection molding.
8. The preparation method of the suppository for preventing and treating canine parvoviral enteritis according to claim 7, wherein the mass of the cellulase is 0.5-1.5% of the mass of the coptis chinensis residue, the enzymolysis temperature is 35-45 ℃, and the enzymolysis time is 3-5h.
9. The method of claim 7, wherein the concentration of the aqueous ethanol solution from which the angelica sinensis extract is prepared is 56% to 60% by volume v/v, the aqueous ethanol solution containing 1.5% to 3.5% by volume m/m sodium chloride; and/or
The concentration of the ethanol aqueous solution for preparing the white peony root extract is 45% -60% v/v, the parameters of ultrasonic extraction are 45% -50Hz, 240% -250W; and/or
The concentration of the aqueous acetic acid solution for preparing the scutellaria baicalensis extract is 0.15% to 0.25% by volume v/v, and the concentration of the aqueous ethanol solution is 40% to 60% by volume v/v.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110975590.XA CN113730481B (en) | 2021-08-24 | 2021-08-24 | Traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, suppository and preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110975590.XA CN113730481B (en) | 2021-08-24 | 2021-08-24 | Traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, suppository and preparation method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113730481A CN113730481A (en) | 2021-12-03 |
CN113730481B true CN113730481B (en) | 2022-12-20 |
Family
ID=78732483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110975590.XA Active CN113730481B (en) | 2021-08-24 | 2021-08-24 | Traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, suppository and preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113730481B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105770136A (en) * | 2016-05-05 | 2016-07-20 | 南宁学院 | Traditional Chinese medicine composition for treating canine parvovirus and preparation method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1443555A (en) * | 2002-10-29 | 2003-09-24 | 胡世英 | Medicine plaster for curing laryngopharyngitis and its preparation method |
CN101670026A (en) * | 2009-08-28 | 2010-03-17 | 天津生机集团股份有限公司 | Chinese and western medicine composition for treating canine parvovirus infection and preparation method thereof |
CN107744510A (en) * | 2017-10-25 | 2018-03-02 | 广东罗浮山国药股份有限公司 | A kind of preparation method of micro-pill type granule |
-
2021
- 2021-08-24 CN CN202110975590.XA patent/CN113730481B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105770136A (en) * | 2016-05-05 | 2016-07-20 | 南宁学院 | Traditional Chinese medicine composition for treating canine parvovirus and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN113730481A (en) | 2021-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104187172B (en) | Functional feed for treating enterogastritis diseases of turtles and preparation method of functional feed | |
CN104012798A (en) | Feed for treating endometritis of sow, traditional Chinese medicine composition and preparation method | |
CN106386694A (en) | Culture method of stocking yellow cattle | |
CN105941932A (en) | Chinese herbal medicine additive for pig feed and preparation method of Chinese herbal medicine additive | |
CN105166544A (en) | Pig mixed feed and preparation method thereof | |
CN104666991A (en) | Pharmaceutical composition capable of preventing pig diarrhea and preparation method of pharmaceutical composition | |
CN106578477A (en) | Special feed for cattle and preparation method of special feed | |
CN104543576B (en) | Prevent and treat composite vegetables extractive feed addictive and its preparation method application of grice diarrhoea | |
CN102973829B (en) | Feed for treating diarrhea of dairy cow | |
WO2020155318A1 (en) | Traditional chinese medicine preparation for treatment of bacterial respiratory tract disease in livestock and production technique thereof | |
CN105168807A (en) | Traditional Chinese medicine composition for treating porcine reproductive and respiratory syndrome and preparation method thereof | |
CN105412892A (en) | Traditional Chinese medicine preparation for treating diarrhea of piglets and preparation method thereof | |
CN111329913B (en) | Compound Shuanghuanglian granular preparation for pets and preparation method thereof | |
CN101390920A (en) | Traditional Chinese medicine for livestock and poultry and preparation method thereof | |
CN113730481B (en) | Traditional Chinese medicine composition for preventing and treating canine parvovirus enteritis, suppository and preparation method | |
CN103768189B (en) | The Chinese medicine for the treatment of cattle hemorrhagic enteritis | |
CN113181317B (en) | Traditional Chinese medicine composition, preparation method thereof and application thereof in preventing diarrhea or resisting diarrhea | |
CN102293952B (en) | Chinese medicinal composition for treating unknown swine fever | |
CN104825753B (en) | A kind of Chinese medicine composition for prevention newborn piglet diarrhea of being taken medicine by sow | |
CN114886961A (en) | Traditional Chinese medicine composition for treating/preventing avian gout and preparation method and application thereof | |
CN107998359A (en) | Control the Chinese medicine and preparation method of Gilt Uterus intimitis and Repeat breeding | |
CN103566312B (en) | Traditional Chinese medicine combination for treating loss of appetite of pigs | |
CN113350429A (en) | Traditional Chinese medicine composition for preventing and treating African swine fever disease and preparation method and application thereof | |
CN101314033A (en) | Oral liquid synergistic agent for livestock, poultry and aquatic product, and preparation method thereof | |
CN107960535A (en) | A kind of feed addictive and its production method for preventing beef cattle gastroenteritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |